Common Queries About Immunizations in Preterm Infants

Area of Science:

• Pediatric infectious diseases
• Vaccinology
• Neonatal care

Background:

• Preterm infants are a vulnerable population with increased susceptibility to vaccine-preventable diseases.
• Delays in routine immunization for preterm infants are prevalent, despite established guidelines.
• Concerns regarding immunogenicity and safety in preterm infants contribute to hesitancy.

Purpose of the Study:

• To review data on the immunogenicity and safety of routine immunizations in preterm infants.
• To address parental and provider concerns regarding vaccination of preterm infants, with or without comorbidities.
• To explore additional strategies for protecting this high-risk population.

Main Methods:

• Comprehensive literature review of studies on preterm infant immunizations.
• Analysis of data on immune response (immunogenicity) and adverse events (safety).
• Evaluation of evidence for protective strategies beyond routine vaccination.

Main Results:

• Routine immunizations are generally safe and immunogenic in preterm infants, regardless of comorbidities.
• Preterm infants mount appropriate immune responses to standard vaccine schedules.
• Evidence supports adherence to chronological age-based immunization schedules.

Conclusions:

• Routine immunization according to chronological age is recommended for all preterm infants.
• Data support the safety and efficacy of vaccines in preterm infants, mitigating risks.
• Further strategies may be considered to enhance protection for this fragile group.